MANUEL
DELGADO ALVARADO
Researcher to 2022
Hospital Universitario Quirónsalud Madrid
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario Quirónsalud Madrid (2)
2023
2021
-
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study
Frontiers in Immunology, Vol. 12